There is no Press for this Ticker
HypGen Inc is a development-stage company principally focused on developing therapeutic treatment options. It is engaged in the business of developing and bringing to market a drug potential to reduce the destruction of neurons that have been associated with Parkinson's disease. Parkinson's disease is a chronic and progressive movement disorder. The company is based in the United States of America.

Related Companies

TickerCompanyChg %Mkt Cap